Treatment of deep vein thrombosis with low molecular weight heparins at home. One year experience;Tratamiento en domicilio de trombosis venosa profunda con heparinas de bajo peso molecular. Experiencia de un año

Anales de Medicina Interna

Volumn 20, Issue 3, 2003, Pages 134-136

  Suarez Alvarez C G ^a   Garcia Canete J ^a   Herrero Mendoza, M D ^a   Bellver Alvarez T M ^a   Arboiro Pinel, R ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Deep vein trombosis; Home care; Low molecular weight heparins; Tinzaparin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOME CARE; HUMAN; MALE; RISK FACTOR; SPAIN; TREATMENT OUTCOME; TUMOR;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0037365346     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in th hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.
2. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, van der Meer J, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight-heparin administered at home. N Engl J Med 1996; 334:682-7.
3. Weitz JI. (editor: Wood AJJ). Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-98.
4. Harrison L, et al. Assessment of outpatient treatment of deep-vein thrombosis with low- molecular-weight heparin. Arch Intern Med 1998; 158: 2001-3.
5. Leibowitz RS. Deep vein thrombosis: Thinking inside out. Arch Intem Med 1998; 158: 1964.
6. Hedner U. Development of tinzaparin: a heparinase-digested low-molecular-weight heparin. Semin Thromb Hemost 2000; 26 (Supl. 1): 23-9.
7. Martineau P, Tawil N. Low-molecular-weight heparins in the treatment of deep-vein thrombosis. Ann Pharmacother 1998; 32: 588-601.
8. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000; 160: 181-88.
9. Gabriel Botella F, Labiós Gómez M, Balaguer Martínez JV, Fernández Llópez A. Prevención de la enfermedad tromboembólica venosa: heparinas no fraccionadas y heparinas de bajo peso molecular. Análisis de estas dos opciones. An Med Interna (Madrid) 1999; 16: 590-600.
10. Low molecular weight heparins for venous thromboembolism (rev). Drug Ther Bull 1998; 36: 25-9.
11. Fegan CD. Tinzaparin as an antithrombotic: an overview. Hosp Med 1998; 59: 145-8.